Providence Cancer Institute

Southfield, Michigan 48075

1 studies enrolling now · 11 studies all time

What they study most

Breast Cancer, COVID, COVID-19, COVID19, Cancer, Carcinoma, Squamous Cell of Head and Neck, Lymphoma, Non-Hodgkin, Neoplasms, Non-Small Cell Lung Cancer, Non-small Cell Lung Cancer, Pain, Post-essential Thrombocythemia Myelofibrosis

Studies at this site

• Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells — Recruiting now
• PRE-VENT Study in Hospitalized Patients With Severe COVID-19 With or Without Cancer — Stopped early
• Rituximab Plus Lenalidomide for Patients With Relapsed / Refractory Indolent Non-Hodgkin's Lymphoma (Follicular Lymphoma and Marginal Zone Lymphoma) — Completed
• Study of Nivolumab (BMS-936558) in Patients With Advanced or Metastatic Squamous Cell Nonsmall-cell Lung Cancer Who Have Received At Least 2 Prior Systemic Regimens — Completed
• Pacritinib Versus Best Available Therapy to Treat Patients With Myelofibrosis and Thrombocytopenia — Stopped early
• NBRST: Prospective Neo-adjuvant REGISTRY Trial — Completed
• Chemotherapy Plus Cetuximab in Combination With VTX-2337 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck — Completed
• Study of EC0489 for the Treatment of Refractory or Metastatic Tumors — Completed
• Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer — Completed
• OraVescent Fentanyl (OVF) for the Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients — Completed
• Study of Carboplatin/Gemcitabine Plus Bevacizumab in Advanced Lung Cancer — Status unconfirmed